Research progress on the role and inhibitors of Keap1 signaling pathway in inflammation

Chao Ding1, Ying Wu2, Chaochao Zhan1

  • 1Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China.

PubMed

Insights

New Keap1 inhibitors targeting the Keap1-Nrf2 pathway offer improved specificity for treating inflammatory diseases. This approach avoids off-target effects common with traditional covalent inhibitors, paving the way for novel drug development.

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Immunology

Background:

  • Inflammation is a key factor in chronic diseases.
  • The Keap1-Nrf2-ARE pathway is crucial for controlling inflammation.
  • Current Keap1 inhibitors often cause off-target effects due to covalent binding.

Purpose of the Study:

  • To review the Keap1-Nrf2-ARE pathway and its role in inflammation.
  • To summarize research on Keap1 inhibitors from 2010-2024.
  • To explore novel non-covalent Keap1 inhibitors for drug discovery.

Main Methods:

  • Literature review of Keap1-Nrf2 pathway research.
  • Analysis of anti-inflammatory drug mechanisms targeting Keap1.
  • Summary of therapeutic roles in inflammatory disease models.

Main Results:

  • The Keap1-Nrf2-ARE pathway is vital in multiple organ inflammation.
  • Non-covalent Keap1 inhibitors show promise for targeted therapy.
  • Research highlights improved specificity and Nrf2 activation.

Conclusions:

  • Targeting Keap1-Nrf2 protein-protein interactions (PPIs) is a promising therapeutic strategy.
  • Non-covalent inhibitors offer enhanced specificity and reduced side effects.
  • This review provides a comprehensive overview of Keap1-targeted anti-inflammatory drug development.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K